World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03083860
Date of registration: 14/03/2017
Prospective Registration: Yes
Primary sponsor: Brainmarc Ltd.
Public title: Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
Scientific title: Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
Date of first enrolment: September 2017
Target sample size: 100
Recruitment status: Not yet recruiting
URL:  https://clinicaltrials.gov/show/NCT03083860
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Device Feasibility. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Israel
Contacts
Name:     David Yarnitzki, MD, Prof.
Address: 
Telephone: 972-47772605
Email:
Affiliation: 
Name:     David Yarnitzki, MD, Prof.
Address: 
Telephone: 972-47772605
Email:
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosed with migraine by a neurologist.

- Male or Female, aged 18 -50 years.

- Having 3-10 migraine attacks per month.

- Able and willing to comply with all study requirements.

- Having Android based smartphone

Exclusion Criteria:

- Diagnosed with chronic pain, neurological or psychiatric disorders.

- Current or past use of anti-depressants.

- A user of recreational or illicit drugs or has had a recent history of drug or alcohol
abuse or dependence.

- History of seizures.

- Head injury with consciousness loss in the last three months.

- Diagnosed as ADHD and/or use of Ritalin.

- Hearing disorder and/or known eardrum impairment.

- Having migraine attacks occurring only during the menstruation.



Age minimum: 18 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
Migraine
Intervention(s)
Device: BEI
Primary Outcome(s)
Evaluation of correlation of attention-related electrophysiological changes and patients' migraine dynamics based at-home EEG measurements via mobile phone app. [Time Frame: 12 months]
Secondary Outcome(s)
Secondary ID(s)
CLD10
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history